FluGen Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol Looks Into Tolerizing Vaccines,

After conditional accelerated approvals were granted in India to Serum Institute of India Pvt. Ltd. ’s COVID-19 vaccine Covishield and Bharat Biotech ’s Covaxin in January, Johnson & Johnson , Pfi

Bharat Biotech has claimed “at least 60%” efficacy for its whole virion, inactivated COVID-19 vaccine candidate Covaxin and is preparing for a launch during the fiscal second quarter ending 30 Septem

Novavax Launches Phase III Trial In UK As Virus Surges Back Novavax, Inc. has launched a Phase III study of its COVID-19 vaccine candidate in the UK, aiming to recruit up to 10,000 subjects to prove